同时训练对乳腺癌幸存者的分子,功能和临床结果的影响:试点研究
Celia García-Chico1, Susana López-Ortiz1, Salvador Santiago-Pescador2
1i+HeALTH Strategic Research Group, Department of Health Sciences, Miguel de Cervantes European University, 47012 Valladolid, Spain.
Cancers
|June 26, 2025
概括
同时训练改善了乳腺癌幸存者 (BCS) 的力量,疼痛和生活质量,而不会增加炎症. 在随访期间,增益保持不变,并观察到炎症标志物减少.
科学领域:
- 运动生理学 运动生理学
- 瘤学康复康复 瘤学康复
- 分子生物学分子生物学
背景情况:
- 乳腺癌幸存者 (BCS) 经常经历长期不良影响,包括与乳腺癌相关的淋巴 (BCRL).
- 运动是BCS推的干预措施,但同时训练对BCRL风险的影响尚不清楚.
- 同时训练结合了有氧和抵抗运动,为BCS提供了潜在的好处.
研究的目的:
- 调查12周监督并发培训计划对BCS分子,功能和临床结果的影响.
- 评估随后的12周禁期对这些结果的影响.
- 评估与炎症相关的蛋白质,身体功能和生活质量的变化.
主要方法:
- 一个单臂研究涉及11个具有或有BCRL风险的BCS.
- 一个为期12周的监督并发培训计划,随后是12周的无培训期.
- 评估92种与炎症相关的蛋白质,上/下肢力量,心肺健康,身体组成,运动范围,疼痛和生活质量 (QoL).
主要成果:
- 12周的同时训练显著增强了上半身肌肉力量,手握力,减轻疼痛,情绪健康和整体体质量.
- 在12周的随访后,排列强度的改善持续了.
- 训练后观察到几个与炎症相关的蛋白质的显著减少,并在随访期间保持.
结论:
- 一个为期12周的并发训练计划是安全有效的,可以提高力量,减少疼痛,并提高BCS中的QoL,而不会加剧炎症.
- 观察到的炎症标志物减少和持续的力量增加表明,并发训练具有长期益处.
- 需要进一步进行大规模的受控研究来验证这些发现,并建立最佳的培训方案.
相关概念视频
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:16Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K